NCT04411446View on ClinicalTrials.gov

Cholecalciferol to Improve the Outcomes of COVID-19 Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

August 11, 2020

Primary Completion Date

July 28, 2021

Study Completion Date

July 28, 2021

Conditions
COVID
Interventions
DRUG

Vitamin D

5 capsules of 100.000 UI Vitamin D orally given all at once. One dose.

DRUG

Placebo

5 capsules of containing placebo orally given all at once. One dose.

Trial Locations (1)

1888

Hospital de Alta Complejidad en Red El Cruce, San Juan Bautista

All Listed Sponsors
collaborator

Agencia Nacional de Investigación y Desarrollo

OTHER

lead

Vitamin D Study Group

NETWORK

NCT04411446 - Cholecalciferol to Improve the Outcomes of COVID-19 Patients | Biotech Hunter | Biotech Hunter